| Citation: |
ZHAO Xiaoxue, WANG Zhongqi. Research Progress in Treatment of Malignant Tumors by Traditional Chinese Medicine Based on Exosomes[J]. Cancer Research on Prevention and Treatment, 2024, 51(2): 80-84. DOI: 10.3971/j.issn.1000-8578.2024.23.1152
|
Malignant tumor is still one of the malignant diseases with high morbidity and mortality in the world. Its occurrence and development are influenced by various factors. Exosomes are nanoscale secretory vesicles that play an important role in the occurrence and development of malignant tumors, and have intercellular communication functions. The mechanism of action of traditional Chinese medicine in prevention and treatment of tumors is not yet comprehensive enough. This article discusses the relationship between exosomes and tumor development, relapse, metastasis and drug resistance, and the application of exosomes in the treatment of malignant tumors by traditional Chinese medicine, to provide reference for finding new breakthroughs in the treatment of malignant tumors.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Wu C, Li M, Meng H, et al. Analysis of status and countermeasures of cancer incidence and mortality in China[J]. Sci China Life Sci, 2019, 62(5): 640-647. doi: 10.1007/s11427-018-9461-5
|
| [2] |
Yu D, Wu Y, Shen HY, et al. Exosomes in development, metastasis and drug resistance of breast cancer[J]. Cancer Sci, 2015, 106(8): 959-964. doi: 10.1111/cas.12715
|
| [3] |
Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity[J]. Biochim Biophys Acta Rev Cancer, 2019, 1871(2): 455-468. doi: 10.1016/j.bbcan.2019.04.004
|
| [4] |
Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478): eaau6977. doi: 10.1126/science.aau6977
|
| [5] |
Stefanius K, Servage K, Orth K. Exosomes in cancer development[J]. Curr Opin Genet Dev, 2021, 66: 83-92. doi: 10.1016/j.gde.2020.12.018
|
| [6] |
Barrès C, Blanc L, Bette-Bobillo P, et al. Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages[J]. Blood, 2010, 115(3): 696-705. doi: 10.1182/blood-2009-07-231449
|
| [7] |
Xu W, Lu M, Xie S, et al. Endoplasmic Reticulum Stress Promotes Prostate Cancer Cells to Release Exosome and Up-regulate PD-L1 Expression via PI3K/Akt Signaling Pathway in Macrophages[J]. J Cancer, 2023, 14(6): 1062-1074. doi: 10.7150/jca.81933
|
| [8] |
Peinado H, Alečković M, Lavavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET[J]. Nat Med, 2012, 18(6): 883-891. doi: 10.1038/nm.2753
|
| [9] |
Syn N, Wang L, Sethi G, et al. Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from Immunosurveillance[J]. Trends Pharmacol Sci, 2016, 37(7): 606-617. doi: 10.1016/j.tips.2016.04.006
|
| [10] |
Paskeh MDA, Entezari M, MirzaeiI S, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling[J]. J Hematol Oncol, 2022, 15(1): 83. doi: 10.1186/s13045-022-01305-4
|
| [11] |
He G, Peng X, Wei S, et al. Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications[J]. Mol Cancer, 2022, 21(1): 19. doi: 10.1186/s12943-021-01440-5
|
| [12] |
Goulet CR, Champagne A, Bernard G, et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling[J]. BMC Cancer, 2019, 19(1): 137. doi: 10.1186/s12885-019-5353-6
|
| [13] |
He Z, Wang J, Zhu C, et al. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis[J]. Cancer Lett, 2022, 548: 215751. doi: 10.1016/j.canlet.2022.215751
|
| [14] |
Jiang X, Chen X. Endometrial cell-derived exosomes facilitate the development of adenomyosis via the IL-6/JAK2/STAT3 pathway[J]. Exp Ther Med, 2023, 26(5): 526. doi: 10.3892/etm.2023.12225
|
| [15] |
Xu J, Zhang J, Zhang Z, et al. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction[J]. Cell Death Dis, 2021, 12(4): 373. doi: 10.1038/s41419-021-03664-1
|
| [16] |
Keklikoglou I, CisnciarusoI C, Guc E, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models[J]. Nat Cell Biol, 2019, 21(2): 190-202. doi: 10.1038/s41556-018-0256-3
|
| [17] |
Guo S, Chen J, Chen F, et al. Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16[J]. Gut, 2022, 71(2): e1-e3. doi: 10.1136/gutjnl-2020-321187corr1
|
| [18] |
卫真真, 季青, 朱惠蓉. 肿瘤微环境中不同细胞来源外泌体对肿瘤耐药的影响及中医药干预研究[J]. 上海中医药大学学报, 2022, 36(2): 1-8. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD202202001.htm
Wei ZZ, Ji Q, Zhu HR. Effects of exosomes from different cellular sources in the tumour microenvironment on tumour drug resistance and the study of Chinese medicine intervention[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2022, 36(2): 1-8. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZD202202001.htm
|
| [19] |
熊文婧, 解园, 靳语书, 等. 外泌体在乳腺癌耐药方面的研究进展[J]. 肿瘤学杂志, 2022, 28(7): 586-589. https://www.cnki.com.cn/Article/CJFDTOTAL-XHON202207010.htm
Xiong WJ, Xie Y, Jin YS, et al. Research progress of exosomes in breast cancer drug resistance[J]. Zhong Liu Xue Za Zhi, 2022, 28(7): 586-589. https://www.cnki.com.cn/Article/CJFDTOTAL-XHON202207010.htm
|
| [20] |
张新飞. SNHG29通过hsa-miR-520h/ABCG2轴及外泌体调控食管鳞癌对顺铂耐药作用机制研究[D]. 石家庄: 河北医科大学, 2023.
Zhang XF. Study on the mechanism of SNHG29 regulating cisplatin resistance in esophageal squamous carcinoma through hsa-miR-520h/ABCG2 axis and exosomes[D]. Shijiazhuang: Hebei Medical University, 2023.
|
| [21] |
Chen X, Gao A, Zhang F, et al. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation[J]. Theranostics, 2021, 11(7): 3392-3416. doi: 10.7150/thno.52435
|
| [22] |
Tekiner TA, Basaga H. Role of microRNA deregulation in breast cancer cell chemoresistance and stemness[J]. Curr Med Chem, 2013, 20(27): 3358-3369. doi: 10.2174/09298673113209990003
|
| [23] |
Yang SM, Huang C, Li XF, et al. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN[J]. Toxicology, 2013, 306: 162-168. doi: 10.1016/j.tox.2013.02.014
|
| [24] |
Guan L, Wu B, Li T, et al. HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8(+) T-cell infiltration into tumors[J]. Nat Commun, 2022, 13(1): 4078. doi: 10.1038/s41467-022-31713-6
|
| [25] |
Xie Z, Gao Y, Ho C, et al. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment[J]. Gut, 2022, 71(3): 568-579. doi: 10.1136/gutjnl-2020-323014
|
| [26] |
Zhou L, Wang W, Wang F, et al. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma[J]. Mol Cancer, 2021, 20(1): 57. doi: 10.1186/s12943-021-01352-4
|
| [27] |
Que ZJ, Luo B, Wang CT, et al. Proteomics analysis of tumor exosomes reveals vital pathways of Jinfukang inhibiting circulating tumor cells metastasis in lung cancer[J]. J Ethnopharmacol, 2020, 256: 112802. doi: 10.1016/j.jep.2020.112802
|
| [28] |
亓润智. 基于肿瘤细胞外泌体调控TAM细胞极化探讨双参颗粒抑制肺癌的作用机制[D]. 北京: 中国中医科学院, 2022.
Qi RZ. Exploring the mechanism of action of Shuangshen granules in inhibiting lung cancer based on the regulation of TAM cell polarisation by tumour cell exosomes[D]. Beijing: China Academy of Traditional Chinese Medicine, 2022.
|
| [29] |
Chen C, Yao X, Xu Y, et al. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche[J]. J Ethnopharmacol, 2019, 238: 111878. doi: 10.1016/j.jep.2019.111878
|
| [30] |
曹如柔. 人结肠癌细胞来源外泌体对裸鼠转移的影响及健脾消癌方干预作用的机制研究[D]. 长沙: 湖南中医药大学, 2022.
Cao RR. Effects of human colon cancer cell-derived exosomes on metastasis in nude mice and the mechanism of the interventional effect of spleen-enhancing and cancer-eliminating formula[D]. Changsha: Hunan University of Traditional Chinese Medicine, 2022.
|
| [31] |
杨傲飞. 基于肾主骨生髓理论研究淫羊藿苷调控外泌体内miR-122-5p对BMSCs成骨、迁移的作用及机制[D]. 武汉: 湖北中医药大学, 2020.
Yang AF. Study on the role and mechanism of miR-122-5p in exocytosis regulated by Icariin on the osteogenesis and migration of BMSCs based on the theory that the kidney is the main bone marrow generator[D]. Wuhan: Hubei University of Traditional Chinese Medicine, 2020.
|
| [32] |
吴桐. 中药白英抗肿瘤物质基础及其干预外泌体抑制非小细胞肺癌转移研究[D]. 北京: 中国中医科学院, 2022.
Wu T. Study on the anti-tumour substance basis of Chinese medicine Baiying and its intervention with exosomes to inhibit metastasis of non-small cell lung cancer[D]. Beijing: China Academy of Traditional Chinese Medicine, 2022.
|
| 1. |
吕安淇，施雨峰，柯佳. 人参皂苷类成分治疗肺癌的研究进展. 中国实验方剂学杂志. 2024(18): 270-280 .
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: